COMMUNIQUÉS West-GlobeNewswire
-
Crescent Biopharma Announces Grants of Inducement Awards
25/09/2026 -
NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
25/09/2026 -
BioAge Labs to Present at Upcoming Investor Conferences
25/09/2026 -
Quest PharmaTech Announces Change of Chief Executive Officer
25/09/2026 -
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
25/09/2026 -
Family-Owned Canadian Supplement Brand Herba Ranks No. 81 on The Globe and Mail’s List of Canada’s Top Growing Companies
25/09/2026 -
Microbot Medical® Highlights Growth Strategy
25/09/2026 -
Global Health Congress 2026 Convenes Health System Leaders, Clinicians, Technologists, Investors and Innovators at the Yale Club of New York City, October 9th-11th
25/09/2026 -
Chrysalis Health and Curaechoice Join Forces to Address Cost and Access Barriers to Mental Health Care
26/09/2026 -
SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer
25/09/2026 -
Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR
25/09/2026 -
Kraig Labs’ Atlas Milestone Opens the Door to Potential Historic Spider Silk Advancements
25/09/2026 -
Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026
25/09/2026 -
Fangzhou Releases 2026 Interim Report, Deepening "AI + Chronic Care" as a Lifetime Health Service Partner
25/09/2026 -
BioSyent Named as One of Canada’s Top Growing Companies 2026 by The Globe and Mail
25/09/2026 -
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS
25/09/2026 -
Newron Provides Update on Phase 3 ENIGMA-TRS 2 Study
25/09/2026 -
OneMedNet Corporation Announces 1-for-10 Reverse Stock Split
25/09/2026 -
Orion Corporation: Acquisition of own shares during week 39, 2026
25/09/2026
Pages